Navigation Links
U of T professor first Canadian woman to win prestigious international science prize
Date:11/10/2008

TORONTO, ON. Eugenia Kumacheva of the University of Toronto's Department of Chemistry has been cited as one of the world's top women scientists.

The L'Oral-UNESCO Women in Science prize only one of five awarded each year is being awarded to Kumacheva for her work in designing and developing new materials with many applications that included targeted drug delivery for cancer treatments and materials for high density optical data storage.

"This marks the first occasion that a Canadian has received this award," says Prof. Kumechava. "I am thrilled."

Kumacheva's research involves working with the sub-structures of polymer particles to create new materials with unique properties. The applications of her work are numerous. Among the many examples are polymer thin films that can be used to encrypt identification documents such as passports, foiling fraud and offering a potentially speedy alternative to waiting in long security checkpoint or government lines.

Her group has also created inexpensive water-based semiconductor nanoparticles capable of boosting light in the infrared spectrum thereby improving the precision of night vision technology. She also developed polymer particles that deliver drugs to a specific diseased site and release them there on demand. And most recently, Kumacheva has been involved in collaborative work on the fabrication of patterned polymer surfaces for the controlled renewal and differentiation of stem cells.

Kumacheva holds the Canada Research Chair in Advanced Polymer Materials.

"As a L'Oral-UNESCO laureate, Prof. Kumacheva joins some of the most extraordinary female scientists in the world," says Scott Mabury, chair of the Department of Chemistry. Other laureates in the program's 10-year history include such eminent scientists as MIT Professor Margaret Dresselhaus, science advisor to former US President Bill Clinton and co-discoverer of carbon nanotubes.

"She
'/>"/>

Contact: Kim Luke
kim.luke@utoronto.ca
416-978-4352
University of Toronto
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
2. University of Iowa professor identifies new eating disorder
3. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
4. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
5. N.J. nurses are overworked according to Rutgers College of Nursing professor
6. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
7. Boston University School of Medicine Professor receives award from American Heart Association
8. Louisiana Tech professor is Small Times Innovator of the Year
9. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
10. Whale music captivates NJIT Professor David Rothenberg for new book, CD
11. Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... and dying hospitalized children ask their physicians to pray ... to such personal requests? While increasing numbers of physicians ... families cope with serious illness, a new study reports ... who raise the issue of prayer, not the doctors ... Medical Journal , Brandeis and Rice University sociologists report ...
(Date:12/16/2009)... agency, is honored to announce that Chris Wepfer and Jackie ... Year in Healthcare Traveler magazine’s 2009 Recruiters of the Year ... received such honors and the first for Jackie. , ... ... Solutions, a national healthcare staffing agency, is honored to announce ...
(Date:12/16/2009)... For ages, people from around the world have visited ... waters have a reputation that dates back over 2000 ... Now, with the introduction of two bath salt lines ... legendary benefits of Dead Sea salt in their own ... Dead Sea salt and essential oils - but no ...
(Date:12/16/2009)... BOCA RATON, Fla., Dec. 16 Dale Buchanan, owner ... has decided to have a weight loss contest for his ... is that the students are not competing for their own ... to raise money for the Tri County Humane Society ... each student of mine loses between January 4 and February ...
(Date:12/16/2009)... access to patient information could improve care, but ... 16 (HealthDay News) -- U.S. physicians support the ... exist about privacy problems, two new studies show. ... practice and specialist doctors in Massachusetts found that ... would improve patient quality of care, 70 percent ...
Breaking Medicine News(10 mins):Health News:Prayer on the hospital floor 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:Pros and Cons of Electronic Medical Records Weighed 2
... Shows Stellar 92 Percent Effective Rate; First For ... lice" become more resistant to some pharmaceutical remedies, ... all-natural head lice product line, Rosemary Repel Hair ... preventing lice from infesting hair follicles.In an in-vitro ...
... is reduced in rodent models of liver injury, ... sulphide, two factors that contribute to endothelial dysfunction ... study the analysis of the human Cystathionase gene ... sequence. Administration of an FXR ligand to carbon ...
... peptide (NP) receptor type B (NPR-B) gene was ... diabetic rats and the expression was increased in ... pGC-cGMP signal is up-regulated and it may contribute ... , Gastroparesis (delayed gastric emptying) is frequent in ...
... Practice and an alliance of businesses in Bucks County, ... and their staff more time to devote to patient ... to help doctors in Bucks County better handle the ... Members of the Bucks County Partners include Doylestown Hospital, ...
... Fixed-dose combination offers a convenient option that may ... pressure goals while decreasing patient pill burden(1)PARSIPPANY, N.J., ... that the United States Food and Drug Administration ... and olmesartan medoxomil) as initial or ,first-line, therapy ...
... Inc. (Nasdaq: GTIV ), a leading provider of ... present at the Deutsche Bank 34th Annual Health Care Conference ... May 19, 2009. The presentations will be available to the ... accessed by visiting http://investors.gentiva.com/events.cfm . ...
Other Medicine News:Health News:'Super Lice' Repelled by All-Natural Products First Ever Independent Study Shows 2Health News:Farnesoid X receptor regulates cystathionase 2Health News:NPs-NPR-B/pGC-cGMP signal pathway is involved in diabetic gastroparesis 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 3Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 2Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 3Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 5Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 6Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 2Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 3
(Date:12/16/2009)... Mass., Dec. 16 Boston Scientific Corporation (NYSE: ... Board of Directors has elected Nelda Connors as a ... of the Electrical and Metal Products division of Tyco ... Eaton Corporation, holding several positions in operations and general ... in a number of executive and management capacities with ...
(Date:12/16/2009)... Mass., Dec. 16 According to Millennium ... technology market intelligence, health care reforms in China ... market in 2009, and will continue to fuel ... Asia Pacific Markets for Interventional Cardiology Devices ... the Chinese government will allow the Chinese drug-eluting ...
(Date:12/16/2009)... /PRNewswire/ -- Sanofi Pasteur, the ... today that it has entered into an ... develop and commercialize its prophylactic vaccine against ... aureus or MRSA. MRSA are responsible ... referred to as multidrug-resistant Staphylococcus aureus ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 1Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 2Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 3Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 1Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 2LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 1LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 2
... the 2009 ASCO MeetingINDIANAPOLIS, May 30 Semafore ... and development company, today presented data from a ... pan-PI3K/mTORC1/2 inhibitor, SF1126, at the 2009 American Society ... in Orlando, Florida.Dr. E. Gabriela Chiorean, from the ...
... 3 study has demonstrated that Induction Chemotherapy ... in comparison to standard ChemoRadiotherapy alone -MADRID, ... Neck Cancer Cooperative Group (TTCC) announced today ... standard ChemoRadiotherapy (CRT), a treatment paradigm defined ...
Other Medicine Technology:Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 2Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 3Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 2Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 3
... for ELISA testing. The system consists of ... Robot, and 1 Plate hotel. The Dade ... of samples from primary tubes via the ... robotic transport system and plate processing via ...
... The Genesis RMP is ideal for ... as for reference and pharmaceutical laboratories. It ... available ELISA and EIA assays from different ... annual throughput of up to 600'000 tests, ...
... IMMULITE and IMMULITE 1000 assays ... the IMMULITE and IMMULITE 1000, ... which offer simplicity in both ... can be found in a ...
... ENA Enzyme-Linked Immunosorbent Assay (ELISA) is intended for ... La, Scl-70, and Jo-1 in human sera. ... detect antibodies in a single serum specimen. ... used as an aid to the diagnosis of ...
Medicine Products: